The pharma sector has faced several challenges in the last few quarters. However, the outlook for the sector appears to be improving due to a moderating trend in raw material and logistics costs, which will help reduce operating costs. Analysts expect the fall in prices in the US market to moderate to a single digit in 2022-23, which should help support profitability. Param Desai, Research Analyst, Prabhudas Lilladher, says: “The US base business will be